Overweight kids show heart risks as teens
Overweight children may show a collection of risk factors for heart disease by the time they are teenagers, a new study shows.
Researchers found that overweight and obese 8-year-olds were seven-times more likely than their thinner peers to have multiple heart disease risk factors at the age of 15. These risks included high blood pressure, unhealthy cholesterol levels and elevations in blood sugar and insulin, a blood-sugar-regulating hormone.
Heavy elderly not at risk of memory decline
Older adults who are overweight do not seem to be at any extra risk of memory decline, a new study suggests.
In fact, researchers found, it was underweight men and women who were more likely to see their memory suffer over time. They speculate that this is because poor nutrition and weight loss may be early manifestations of Alzheimer’s disease in some older people.
Europe gives final approval to Pfizer HIV drug
Pfizer Inc said on Monday the European Commission had approved its AIDS drug called Celsentri, or Selzentry in the United States, the first in a new class of oral HIV medicines.
The drug—which is known generically as maraviroc—is the first designed to keep HIV, the virus that causes AIDS, from entering healthy immune cells. Older AIDS medicines attack the virus itself.
Pain meds may worsen symptoms of enlarged prostate
Common painkillers like ibuprofen and naproxen may act as a double-edged sword when it comes to men’s prostate function, according to a report in the Harvard Men’s Health Watch.
Recent evidence suggests that drugs such as these, called nonsteroidal anti-inflammatory drugs (NSAID), may lower the risk of developing an enlarged prostate and worsen urinary symptoms in men who already have the condition.
Roche says Avastin effective in colorectal cancer
New clinical data showed Avastin improved the chances of a removal of metastatic lesions in patients with colorectal cancer, Swiss drug maker Roche Holding said on Monday.
New data from the large international First BEAT trial demonstrated that a high number of patients treated with Avastin plus standard chemotherapy for colorectal cancer had metastatic lesions completely removed, Roche said.
